| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |